- About Allist
- R & D
The 2021 CHC-CITIC Securities Healthcare Conference, also the 10th China Healthcare Investment CEO Conference, was held in Shanghai on April 7 and 8 this year. The event brought hundreds of leading experts and practitioners in the field of healthcare together for an in-depth, multi-dimensional, and multi-perspective exchange of information and insights as well as a demonstration of innovative technologies.
Ms. Sandy Mu, CEO of Allist, delivered a speech on “How Biotech Translates into Bio Pharma/Big Pharma” at the panel discussion on biomedicines session. After 17 years of unswerving dedication to innovation and entrepreneurship, Allist has become a pharmaceutical enterprise that integrates research and development, production, and marketing. It is devoted to becoming a frontrunner in the field of special drugs to bring benefits to more patients in need.
In addition, at the gala dinner of the conference, the list of the best healthcare investments in 2020 was revealed, and Allist made it into the top 10 listed biopharmaceutical companies.